Recombinant Interleukin-2 (aldesleukin) for oncology and HIV disease and recombinant protein treatment (Fabrazyme) for Fabry's disease (No. 14 in a series of articles to promote a better understanding of the use of genetic engineering)

✍ Scribed by Greg Baigent; Debra Barngrover

• Book ID: 119524183
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 82 KB
• Volume: 95
• Category: Article
• ISSN: 0168-1656
• DOI: 10.1016/s0168-1656(02)00019-6